Dignitana AB (EM) (DIZTF)

from Dec 11th, 2016 A new clinical trial for a cooling cap system that was approved just last year was halted midway because the results were so extraordinary: 51 percent of the 95 breast cancer patients who used it and went through four cycles of chemotherapy were able to keep their hair, versus absolutely none of the 47 patients in the control who group who didn’t use it.

Helping women keep their hair during Chemo is an outstanding achievement. This will become useful to not only help self esteem but provide a huge emotional lift for those with cancer.